AMAG
AMAG Pharmaceuticals
AMAG
AMAG
Delisted
AMAG was delisted on the 13th of November, 2020.
197 hedge funds and large institutions have $2.18B invested in AMAG Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
62% less call options, than puts
Call options by funds: $1.16M | Put options by funds: $3.04M
Holders
197
Holding in Top 10
8
Calls
$1.16M
Puts
$3.04M
Top Buyers
| 1 | +$176M | |
| 2 | +$62.7M | |
| 3 | +$40.1M | |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$38.8M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$37.1M |
Top Sellers
| 1 | -$104M | |
| 2 | -$28.1M | |
| 3 | -$24.5M | |
| 4 |
BC
Broadfin Capital
New York
|
-$24.4M |
| 5 |
GCM
Greywolf Capital Management
Purchase,
New York
|
-$23.3M |